Not quite yet IMO. We should move up from here for reasons previously given but there is no doubt in my mind this stock is 1 piece of good news away from making a very serious move upward.
I have read on other chat boards that this stock could run as high $7, $70 or even $700 a share. The middle one is definitely possible IMO.
You see the vast percentage of hospital patients in the end actually die of sepsis even though it was another disease which caused them to develop that. A system which can eradicate that, buying the patients more time and improving their overall health is not to be overlooked IMO. And as for Dr Chan, I think he knows what he is doing.
Market Data 
Markets 
AI
